NTBL:US
$0.248
-
0.00%
Notable Labs Ltd.News & Events
Last updated: Jun 25, 2025, 7:36 PM ET
Notable Labs to Present Data on September 4th at SOHO 2024
GlobeNewswire AUG 29, 2024 7:30 AM EDTSociety of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 ...READ ARTICLENotable Labs Announces CEO Transition
GlobeNewswire AUG 26, 2024 4:05 PM EDTThomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company ...READ ARTICLENotable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
GlobeNewswire JUL 24, 2024 7:30 AM EDTFOSTER CITY, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“...READ ARTICLESHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vascular Biogenics Ltd. Merger
Newsfile FEB 23, 2023 3:36 PM ESTWilmington, Delaware--(Newsfile Corp. - February 23, 2023) - Rigrodsky Law, P.A. is investigating...READ ARTICLEInvestor Network: Vascular Biogenics Ltd. to Host Earnings Call
ACCESS Newswire AUG 14, 2017 6:01 AM EDTNEW YORK, NY / ACCESSWIRE / August 14, 2017 / Vascular Biogenics Ltd. (NASDAQ: VBLT ) wil...READ ARTICLEAnalyst Insights behind Price Movement - Research on Vascular Biogenics, Hutchinson Technology, Tonix Pharmaceuticals and Nymox Pharmaceutical
ACCESS Newswire NOV 23, 2015 8:40 AM ESTNEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new re...READ ARTICLE